CoChat

Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members

Open access

The DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index; 19 of the 58 sources its claims cite were checked for support.

Abstract

We examined the role of hepatic heparan sulfate in triglyceride-rich lipoprotein metabolism by inactivating the biosynthetic gene GlcNAc N-deacetylase/N-sulfotransferase 1 (Ndst1) in hepatocytes using the Cre-loxP system, which resulted in an approximately 50% reduction in sulfation of liver heparan sulfate. Mice were viable and healthy, but they accumulated triglyceride-rich lipoprotein particles containing apoB-100, apoB-48, apoE, and apoCI-IV. Compounding the mutation with LDL receptor deficiency caused enhanced accumulation of both cholesterol- and triglyceride-rich particles compared with mice lacking only LDL receptors, suggesting that heparan sulfate participates in the clearance of cholesterol-rich lipoproteins as well. Mutant mice synthesized VLDL normally but showed reduced plasma clearance of human VLDL and a corresponding reduction in hepatic VLDL uptake. Retinyl ester excursion studies revealed that clearance of intestinally derived lipoproteins also depended on hepatocyte heparan sulfate. These findings show that under normal physiological conditions, hepatic heparan sulfate proteoglycans play a crucial role in the clearance of both intestinally derived and hepatic lipoprotein particles.

Overview

Integrity signals

Registry

Crossref · 10.1172/jci29154

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

14 Valid · 1 Not valid · 22 Not checked · 102 Own results and interpretations

75 more claims · 4 with their cited sources checked

Create a free account to see all 139 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 23
  • It may state two separate claims as one. 39
  • The quote only partly states this claim. 4

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 90 references

Research works printed but not linked: 2

  1. Belting, M. 2003. Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem. Sci. 28:145-151. · DOI · Paper page
  2. Iverius, P., and Ostlund-Lindqvist, A. 1986. Prepa- ration, characterization, and measurement of lipo- protein lipase. In Methods in enzymology. J.J. Albers and J.P. Segrest, editors. Academic Press. Orlando, Florida, USA. 691-704.

Cited by

Items 201–224 of 224

Metadata

Authors
MacArthur, J. M., Bishop, J. R., Stanford, K. I., Wang, L., Bensadoun, A., Witztum, J. L., & Esko, J. D.
Affiliations
  • University of California San Diego (US)
  • Cornell University (US)
Venue
Journal of Clinical Investigation
Published
2007-01-02
Volume
117
Issue
1
Pages
153-164
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2157280645
Cited by
216
References
91
Citations by year
2026: 2 · 2025: 7 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 9 · 2020: 4 · 2019: 7 · 2018: 8 · 2017: 9 · 2016: 14 · 2015: 12 · 2014: 17 · 2013: 14 · 2012: 11
FWCI
17.55
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Science Foundation
  • National Institutes of Health (HL57345, GM33063)
  • University of California, San Diego
  • National Heart, Lung, and Blood Institute (HL 57345, P50HL056989, P01HL057345, HL-56989)
  • National Institute of General Medical Sciences (R01GM033063, R37GM033063, GM-33063)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
Keywords
heparan sulfate proteoglycans, triglyceride-rich lipoproteins, lipoprotein clearance, NDST1, LDL receptor, hepatic lipoprotein metabolism, apolipoproteins
MeSH terms
Apolipoproteins E, Humans, Lipoproteins, Liver, Receptors, LDL, Triglycerides, Hypertriglyceridemia, Fibroblast Growth Factor 2, Heparan Sulfate Proteoglycans, Hepatocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-11-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.